------------------------------
OMB APPROVAL
------------------------------
------ OMB Number 3235-0104
FORM 3 Expires: December 31, 2001
------ Estimated average burden
hours per response ....... 0.5
------------------------------
U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
Section 17(a) of the Public Utility Holding Company Act of 1935 or Section
30(f) of the Investment Company Act of 1940
================================================================================
1. Name and Address of Reporting Person
Howe Steve R
- --------------------------------------------------------------------------------
(Last) (First) (Middle)
1512 Webster Court
- --------------------------------------------------------------------------------
(Street)
Fort Collins Colorado 80524
- --------------------------------------------------------------------------------
(City) (State) (Zip)
================================================================================
2. Date of Event Requiring Statement (Month/Day/Year)
March 2000
================================================================================
3. IRS or Social Security Number of Reporting Person (Voluntary)
================================================================================
4. Issuer Name and Ticker or Trading Symbol
Verex Laboratories, Inc. -- VRXL.OB
================================================================================
5. Relationship of Reporting Person to Issuer (Check all applicable)
[ ] Director [X] 10% Owner
[ ] Officer (give title below) [ ] Other (specify below)
--------------------------------------------------------------------
================================================================================
6. If Amendment, Date of Original (Month/Year)
================================================================================
7. Individual or Joint/Group Filing (Check applicable line)
[X] Form filed by one Reporting Person
[ ] Form filed by more than one Reporting Person
================================================================================
<PAGE>
FORM 3 (continued)
Table I -- Non-Derivative Securities Beneficially Owned
================================================================================
3.Ownership Form:
1.Title of 2.Amount of Securities Direct (D) or 4. Nature of Indirect
Security Beneficially Owned Indirect (I) Beneficial Ownership
(Instr. 4) (Instr. 4) (Instr. 5) (Instr.5)
- --------------------------------------------------------------------------------
Common Stock 1,345,517 I By PR Pharmaceuticals, Inc. (1)
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
================================================================================
Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly.
<TABLE>
<CAPTION>
Table II -- Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
===================================================================================================
<S> <C> <C> <C> <C> <C>
3. Title and Amount 5.Owner-
of Securities Underlying ship
Derivative Security Form of
2. Date Exercisable (Instr. 4) Derivative
and Expiration Date ------------------------ 4. Conver- Security:
(Month/Day/Year) Amount sion or Direct 6. Nature of
1. Title of -------------------- or Exercise (D) or Indirect
Derivative Date Expira- Number Price of Indirect Beneficial
Security Exer- tion of Derivative (I) Ownership
(Instr. 4) cisable Date Title Shares Security (Instr.5) (Instr. 5)
- ---------------------------------------------------------------------------------------------------
Not Applicable
- ---------------------------------------------------------------------------------------------------
- ---------------------------------------------------------------------------------------------------
===================================================================================================
</TABLE>
Explanation of Responses:
(1) The reporting person owns 26.56% of PR Pharmaceuticals, Inc. ("PRP") and
serves as one of the three trustees for a trust holding 1,900,000 shares of
PRP. The reporting person disclaims beneficial ownership of all shares of
Verex, except to the extent of his pro rata indirect interest through PRP.
/s/ Steve R. Howe 4/10/00
------------------------------- -----------
**Signature of Reporting Person Date
** Intentional misstatements or omissions of facts constitute Federal Criminal
Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
